SPEAKERS

Dr. Noopur Raje, MD

Professor of Medicine
Harvard Medical School
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Boston, Massachusetts

Dr. Noopur Raje received her medical degree from B.J. Medical College, Pune University, India. She has trained in internal medicine at Massachusetts General Hospital (MGH) and has completed a fellowship in hematology and medical oncology at the Dana-Farber Cancer Institute, Boston. Dr. Raje has a joint faculty appointment at MGH and Dana-Farber Cancer Institute. She is a professor of medicine at Harvard Medical School and is the director of the Multiple Myeloma Program, Medical Oncology, at MGH. As a hematologist/oncologist at MGH, Dr. Raje’s primary focus is in multiple myeloma and related research. Her laboratory focuses on bone biology and the development of novel therapeutics for multiple myeloma, as well as identifying and validating novel targets and translating them into clinical trials.

Dr. Raje is a member of the American Medical Association, America Society of Hematology, American Society of Clinical Oncology, and American Association of Cancer Research, she is also an ad hoc reviewer for several journals including Blood, Clinical Cancer Research, Leukemia, and the American Journal of Hematology. Dr. Raje is the recipient of several awards and has published extensively in the field of multiple myeloma research. Her hope is to continue pursing laboratory and clinical research in the area of multiple myeloma with the goal of translating her efforts to the improvement of patients’ lives.

Dr. Kerry Savage, BSc, MD, MSc

Medical Oncologist at the BC Cancer Agency,
Assistant Professor at the University of British Columbia

Dr Kerry Savage is an Associate Professor with the University of British Columbia and she is a Medical Oncologist and Clinical Scientist at the BC Cancer Agency with the lymphoma tumour group, since 2003. She obtained her medical degree at the University of British Columbia in 1996 and received a Masters of Science in Epidemiology at the Harvard School of Public Health in 2004. Prior to working at British Columbia Cancer Agency, she spent two years at the Dana Farber Cancer Institute in Boston to complete a Lymphoma Research Fellowship under the supervision of Dr. Shipp.
Dr Savage’s research interests include all of the lymphoid cancers with particular interest and the training of new clinical fellows.

Professor H. Miles Prince, AM, MBBS (Hons), MD, FRACP, FRCPA, AFRCMA, MACD, FAHMS

Professor, University of Melbourne
Professor, Monash University
Professor/Director of Molecular Oncology and Cancer Immunology, Epworth Healthcare
Director, Centre for Blood Cell Therapies, Peter MacCallum Cancer Centre

Professor Miles Prince is a specialist haematologist who manages all types of blood-related conditions which include anaemia, bleeding and blood clotting disorders, as well as cancers of the blood. He is a full professor at both The University of Melbourne and Monash University.
Professor Prince is involved in major research programs involving stem cell research and the mechanism of the immune systems control of blood and cancer growth. He is also involved in many clinical trials related to this research. He holds major Australian, American and European research grants and has published over 300 journal articles. Professor Prince is a member of Australian, American and European Societies of Haematology and Oncology, and is on the boards of International SOciety of cutaneous lymphoma, InternationalWaldenstrom’s macroglobulinemia Foundation and chairman of the Medical Scientific Advisory Group of Myeloma Australia. Professor Prince has recently been appointed Director of Molecular Oncology and Cancer Immunology at the Epworth Hospital